PolyPeptide Group AG (XSWX:PPGN) COGS-to-Revenue : 0.91 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is PolyPeptide Group AG COGS-to-Revenue?

PolyPeptide Group AG's Cost of Goods Sold for the six months ended in Dec. 2023 was CHF161.9 Mil. Its Revenue for the six months ended in Dec. 2023 was CHF177.8 Mil.

PolyPeptide Group AG's COGS to Revenue for the six months ended in Dec. 2023 was 0.91.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. PolyPeptide Group AG's Gross Margin % for the six months ended in Dec. 2023 was 8.92%.

PolyPeptide Group AG COGS-to-Revenue Historical Data

The historical data trend for PolyPeptide Group AG's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PolyPeptide Group AG COGS-to-Revenue Chart

PolyPeptide Group AG Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.71

0.68

0.65

0.81

0.99

PolyPeptide Group AG Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
COGS-to-Revenue	Get a 7-Day Free Trial					0.65	0.72	0.90	1.09	0.91

PolyPeptide Group AG COGS-to-Revenue Calculation

PolyPeptide Group AG's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	297.757	/	302.135
	=	0.99

PolyPeptide Group AG's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	161.949	/	177.806
	=	0.91

PolyPeptide Group AG (XSWX:PPGN) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

PolyPeptide Group AG's Gross Margin % for the six months ended in Dec. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	161.949 / 177.806
	=	8.92 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

PolyPeptide Group AG COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of PolyPeptide Group AG's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

PolyPeptide Group AG (XSWX:PPGN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PolyPeptide Group AG (XSWX:PPGN) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

PPGNz:UK

Address

Neuhofstrasse 24, Baar, Zug, CHE, 6340

Website

https://www.polypeptide.com

PolyPeptide Group AG is an independent contract development and manufacturing organization (CDMO) focused on peptides and oligonucleotides employed as an active pharmaceutical ingredients (APIs) and used as intermediates in therapeutic products. The company derives a majority of its revenue from Europe and Asia.

PolyPeptide Group AG (XSWX:PPGN) Headlines

No Headlines